Table I Index
Table of Contents
|
Table I - 32 Hendricks Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 313 | 337.6 | 165 | 395.3 | 148 | 294.6 |
| Oral cavity and pharynx | 8 | 7.8** | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 57 | 62.4 | 33 | 77.8 | 24 | 48.3 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 25 | 27.7 | 15 | 36.5** | 10 | 20.0** |
| Rectum and rectosigmoid | 15 | 16.4** | 9 | 22.3** | 6 | 11.9** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | * | # | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 49 | 53.5 | 35 | 89.9 | 14 | 25.6** |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 6 | 6.4** | * | # | * | # |
| Lung and bronchus | 43 | 47.1 | 32 | 81.6 | 11 | 19.5** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 12 | 10.7** | 7 | 11.4** | 5 | 10.4** |
| Melanoma of the skin | 11 | 9.6** | 6 | 9.0** | 5 | 10.4** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 55 | 56.9 | * | # | 55 | 108.8 |
| Female genital system | 21 | 22.0 | -- | -- | 21 | 43.2 |
| Cervix uteri | 6 | 4.7** | -- | -- | 6 | 9.5** |
| Corpus uteri | 6 | 6.7** | -- | -- | 6 | 13.5** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 7 | 8.3** | -- | -- | 7 | 15.7** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 43 | 49.4 | 43 | 107.8 | -- | -- |
| Prostate gland | 41 | 48.0 | 41 | 105.0 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 23 | 25.1 | 19 | 44.7** | * | # |
| Urinary bladder | 16 | 16.9** | 13 | 30.1** | * | # |
| Kidney and renal pelvis | 6 | 7.1** | 5 | 12.1** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 5 | 7.4** | * | # | * | # |
| Brain | 5 | 7.4** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 7 | 6.8** | * | # | 5 | 9.1** |
| Thyroid gland | 7 | 6.8** | * | # | 5 | 9.1** |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 14 | 14.8** | 9 | 19.6** | 5 | 10.2** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 13 | 14.1** | 8 | 18.3** | 5 | 10.2** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 8 | 8.5** | 6 | 13.5** | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | * | # | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||